Patient-Reported Outcomes in the CONVINCE Trial

Patient-reported outcomes (PROs) are pivotal in advancing renal replacement therapies and guiding patient-centered care. Recent findings from the CONVINCE trial demonstrate the superiority of high-volume hemodiafiltration, which improves life expectancy, slows the decline in physical and cognitive function, and enhance participation in social activities, compared to standard hemodialysis.

Press the CLICK HERE or Register button to view.